ARTICLE | Financial News

AI company twoXAR raises $10M series A

March 19, 2018 10:40 AM UTC

AI company twoXAR Inc. (Palo Alto, Calif.) raised $10 million in an untranched series A round led by new investor SoftBank Ventures. Existing investor Andreessen Horowitz Bio Fund and new investor OS Fund also participated.

The company is using its AI platform to rapidly identify drug candidates and has developed compounds to treat liver cancer, rheumatoid arthritis and Type II diabetes. CEO Andrew A. Radin said the company hopes to launch six to eight new programs over the next year...

BCIQ Company Profiles

Aria Pharmaceuticals Inc.